Selected passages from the FDA letter
Quoted FDA text from the published dataset. These selected excerpts are not the complete letter.
Passage 1Failure to adequately establish procedures for identifying product during all stages of receipt, production, distribution, and installation, as required by 21 CFR §820.60.
Passage 2Failure to adequately maintain quality system records, as required by 21 CFR § 820.186.
Citations in the original letter
As cited in this historical letter, not a statement of current regulatory requirements.
- 21 CFR 820.60
- 21 CFR 820.186